DUSP7

Across TCGA pan-cancer cohorts, DUSP7 mass-spec protein is linked to patient survival in 3 of 34 cancer types, making it a survival-associated DUSP7 data layer compared with 28 for mass-spec protein and 7 for mutation status.

The strongest signal is observed in pancreatic ductal adenocarcinoma (PDAC), where higher DUSP7 mass-spec protein is associated with worse overall survival. In most high-consensus cancer types, elevated DUSP7 expression acts as an unfavorable survival marker.

PDAC, LSCC, and LUAD are the cancer types where DUSP7 mass-spec protein most reproducibly stratifies survival.

mass-spec protein survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
PDAC	OS	Median	All	0.241	0.874	.002	48	view →
LSCC	OS	Tertile	II,III,IV	0.765	0.997	.023	5	view →
LUAD	OS	Median	III,IV	0.719	0.995	.048	1	view →

Pink = unfavorable, green = favorable. Showing the 3 strongest of 3 lineages.

DUSP7–PDAC (OS)

Open the PDAC breakdown →